openPR Logo
Press release

Cancer Biomarkers Market Huge Growth In Coming Year | Top Players Abbott Laboratories; F.Hoffmann-La Roche Ltd.; QIAGEN; Thermo Fisher Scientific Inc.; Affymetrix Inc.; Illumina, Inc.; Agilent Technologies; Merck & Co. Inc.; Hologic, Inc.; Sino Biological

07-14-2019 07:00 PM CET | Health & Medicine

Press release from: Cancer Biomarkers

Cancer Biomarkers

Cancer Biomarkers

The global Cancer Biomarkers Marketwas valued at USD 10.19 billion in 2016 and is projected to reach USD 28.03billion by 2025, growing at a CAGR of 11.9% from 2017 to 2025.

Cancer Biomarkers have high usage in Cancer diagnostics and treatment, especially in Tissue specific therapies. Therefore market of this genetically engineered product is seeing high values in terms of market value.

Cancer is reported to be second leading cause of mortality in the U.S. after cardiovascular disorders. Prevalence of breast, prostate, and lung malignancies has increased at a very steep rate with an estimated number of over 1,600 people being affected in the U.S. every year. In 2017, around 200,000 cases of breast cancer have been reported in the U.S.

Increasing awareness amongst patients and healthcare professionals about the importance of early diagnosis of malignancies and rising demand for personalized medicine is anticipated to provide this market with high growth opportunities in the coming decade. Diagnostic biomarkers for early diagnosis enable doctors on deciding better treatment alternatives leading to successful recovery in lesser time.

Request for Sample of this Report@ https://flairinsights.com/requestsample/261

In addition, increasing regulatory approval of novel drugs and diagnostics pertaining to cancer biomarkers is estimated to increase the adoption rate. For instance, in 2016, Epigenomics AG, a company involved in the development of novel epigenetic biomarker test announced that its Epi proColon was included by the Chinese government for colorectal cancer (CRC) screening.

Type Insights

Based on type, the market is categorized into breast, prostate, colorectal, cervical, liver, and lung. Breast cancer was the largest segment in 2016. Breast, lung, and prostate cancer cumulatively held the revenue share of over 40% in 2016. Increasing awareness about early testing and growing base of target population are the key factors contributing toward dominance

On the other hand, lung cancer is expected to witness fastest growth over the forecast period. Growing number of diagnostic tests targeting EGFR and BRAF mutations, which act as an essential biomarker for diagnosis of non-small cell lung cancer are anticipated to accentuate the segment growth.

Biomolecule Insights

Based on the biomolecule, the market is further segmented into genetic, epigenetic, metabolic, and proteomic biomarkers. Genetic biomarkers owing to their extensive usage, high-reliability rate, and easier analysis held a significant market share. Over 85% of malignancies are reported to be detected with the help of genetic and proteomic biomarkers.

Epigenetics has gained high acceptance in field of cancer diagnostics. High amount of research is being undertaken by many players for the analysis of key epigenetic modification related to cancer for further development of biomarker targeting drugs. Increasing collaboration between and pharmaceutical companies for the development of novel drugs targeting epigenetic biomarkers is estimated to boost growth of this segment.

Application Insights

Cancer biomolecules find application in various fields such as drug discovery and development, diagnostics, and personalized medicine. Diagnostics were the key revenue-generating application of the market pertaining to factors such as increasing development of biomarker-based oncology tests with high specificity and sensitivity.

Personalized medicine owing to its increasing demand and rising awareness amongst healthcare professionals is anticipated to witness flourishing growth rate. Moreover, growing approval for companion diagnostic tests for cancer drugs is expected to affirm market growth.

Regional Insights

North America dominated the regional segment followed closely by Europe. High adoption of innovative technology, presence of key pharmaceutical companies, established R&D infrastructure pertaining to the development of novel diagnostic products and increased demand for specific & early diagnostics are the major factors for aforementioned dominance.

However, the Asia Pacific region owing to increasing prevalence of cancer, beneficial environment for clinical trials, and increasing government funding for supporting drug development programs is anticipated to witness lucrative CAGR over the forecast period. Moreover, growing focus of pharmaceutical companies over this region coupled with rising awareness for biomarker-based diagnosis is one of the high impact-rendering driver for growth.

Inquire for further detailed information of Cancer Biomarkers Market Report at: https://flairinsights.com/send-a-query/261

Competitive Insights

Abbott Laboratories; F.Hoffmann-La Roche Ltd.; QIAGEN; Thermo Fisher Scientific Inc.; Affymetrix Inc.; Illumina, Inc.; Agilent Technologies; Merck & Co. Inc.; Hologic, Inc.; Sino Biological Inc.; and Becton, Dickinson and Company are some of the key players of the market.

About Us:

Flair Insights provides research that fuels innovation. Today’s modern world runs on sound research and development for which big data is required. We now live in the world of information where everything can be quantified. Flair Insights provides comprehensive analysis and reports that cover a wide range of industries. These reports will help you understand the industry and subject it is about and provide you with the right insights. Businesses can then make sound strategies based on the reports, make predictions, understand market trends, do surveys and more. The reports are a microscopic look that unveil the minutest of details.

Contact Us:

Name: Yog Thakre
Email: sales@flairinsights.com
Organization: Flair Insights
Address: 5, Kapre Complex, Suncity Road, Anand Nagar,
Pune, Maharashtra - 411051
Phone: +91 89561 90780
Website: www.flairinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Biomarkers Market Huge Growth In Coming Year | Top Players Abbott Laboratories; F.Hoffmann-La Roche Ltd.; QIAGEN; Thermo Fisher Scientific Inc.; Affymetrix Inc.; Illumina, Inc.; Agilent Technologies; Merck & Co. Inc.; Hologic, Inc.; Sino Biological here

News-ID: 1803429 • Views:

More Releases from Cancer Biomarkers

Dramatic Improvement In Cancer Biomarkers In Global Market Will Increase Demand During The Period 2017 - 2025
Dramatic Improvement In Cancer Biomarkers In Global Market Will Increase Demand …
Researchmoz added Most up-to-date research on "Dramatic Improvement In Cancer Biomarkers In Global Market Will Increase Demand During The Period 2017 - 2025" to its huge collection of research reports. Biomarkers are the substance or molecules found in blood, other body fluids or tissues which states the normal and abnormal condition of the body, biomarkers helps to detect various diseases such as cancer. Cancer biomarkers tests are carried out to detect

More Releases for Increasing

Increasing Focus On Using Lightweight Materials Is Increasing Demand For Two Com …
Two Component Adhesives Market Overview Two component adhesives are binding substances known for adhesions that are led by chemical reactions. These adhesives are sometimes recognized as reactive adhesives or structural adhesives. To Get In-depth Information View Full Report – https://www.factmr.com/report/5376/two-component-adhesives-market Two component adhesives are known for their fast curing, easy process due to their creamy consistency, flawless shine after mechanical polishing, high chemical and wear resistance, and high bonding power even at high
Torso Model : increasing use of torso model in the medical industry, increasing …
Torso Model Market Overview The torso or trunk is an anatomical name for the central part, or core, extending the neck and limbs. The torso includes the trunk's thoracic segment, the abdominal segment of the trunk, and the perineum. Human torso models are both complicated and rich in detail as the torso contains many vital organs. Doctors and medical instructors employ torso manikins to illustrate the complex structure and functions of
Thyristor Market - The Increasing Demand From Increasing Population 
Published: Oct, 2018 The global thyristor market was valued at US$ 4,035.0 Mn in 2017 and is projected to register compound annual growth rate (CAGR) of over 7.0% from 2018 to 2026, according to a new report published by Transparency Market Research (TMR) titled “Thyristor Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.” The report suggests that the rising population and urbanization is likely to spur the
Growth of the Global PVC Pipes and Fittings Market is Increasing With Increasing …
PVC Pipes and fittings are made from the polyvinyl chloride material. PVC pipes and fittings are manufactured by heating plastic resins and the molten resins are set to make desirable shapes and sizes. The PVC pipes and fittings are widely used in the various applications such as irrigation, building & construction, water supply, sewage management and others. PVC pipes and fittings are of various types such as rigid pipes and
Thick Film Resistors Market - Increasing Consumer Spending And Increasing Global …
Resistor is a two-terminal electronic component that is used to resist or reduce the amount of current flowing in an electronic circuit. A resistor is diverse component which comes in variety of resistance values, sizes, shapes and types and these different types of resistors are used in different applications. Resistors can be broadly categorized as fixed resistors and variable resistors. Thick film resistor is one of the fixed resistors, these
Increasing Health Sensitivity Among Consumers Is Boosted By Increasing Health Se …
SAN FRANCISCO, Nov. 09, 2017 Global Nutraceuticals Product Market size is expected to reach $340 billion by 2024 from $195 billion in 2016; growing at a CAGR of 7.2% from 2016 to 2024. By geography, Asia-Pacific and Rest of the World are expected to grow at a CAGR of 7.6% and 7.7%, respectively, during the forecast period. Click Here to Request a Free Sample PDF of This Report @ https://www.variantmarketresearch.com/report-categories/food-beverages/nutraceuticals-market/sample-request Increasing investments